0.54 USD
▲+0.00+0.06%
盘后 0.58 0.00%
2026-09-16
市值
$1.48M
市盈率
—
EPS
-1.60
股息率
—
52 周区间
0.51 – 2.89
成交量
12.75K
Beta
0.50
目标价
—
52W 低 0.5152W 高 2.89
价格走势
公司简介
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or b...